Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
The industry rank for PT Lippo Karawaci Tbk's 9-Day RSI or its related term are showing as below:
ISX:LPKR's 9-Day RSI is ranked worse than 70.34% of 698
companies
in the Healthcare Providers & Services industry
Industry Median: 50.77
vs ISX:LPKR: 59.23
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
PT Lippo Karawaci Tbk 9-Day RSI Related Terms
ISX:LPKR vs HCA, THC, DVA: 9-Day RSI Comparison
For the Medical Care Facilities subindustry, PT Lippo Karawaci Tbk's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Lippo Karawaci Tbk 9-Day RSI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Lippo Karawaci Tbk's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where PT Lippo Karawaci Tbk's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Lippo Karawaci Tbk (ISX:LPKR) has a 9-Day RSI of 59.23 as of Jul. 17, 2026. According to the industry distribution chart, PT Lippo Karawaci Tbk ranks #491 out of 698 companies in the Healthcare Providers & Services industry, placing it in the top 70.3%.
Is PT Lippo Karawaci Tbk's 9-Day RSI too high?
PT Lippo Karawaci Tbk's current 9-Day RSI is 59.23. The Healthcare Providers & Services industry median 9-Day RSI is 50.77. PT Lippo Karawaci Tbk's value of 59.23 is 16.7% above this industry median. Based on the distribution chart, PT Lippo Karawaci Tbk ranks #491 out of 698 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, PT Lippo Karawaci Tbk has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PT Lippo Karawaci Tbk's 9-Day RSI compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Lippo Karawaci Tbk ranks #491 out of 698 companies for 9-Day RSI. This places PT Lippo Karawaci Tbk in the lower half of its industry. The industry median 9-Day RSI is 50.77. PT Lippo Karawaci Tbk's value of 59.23 is 16.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Healthcare Providers & Services company?
The median 9-Day RSI among Healthcare Providers & Services companies is 50.77, based on 698 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Lippo Karawaci Tbk's current 9-Day RSI of 59.23 is 16.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median 9-Day RSI is 50.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Lippo Karawaci Tbk's current 9-Day RSI is 59.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Lippo Karawaci Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Lippo Karawaci Tbk (ISX:LPKR) is currently considered Fairly Valued. The stock's GF Value™ is Rp60.78, compared to a current price of Rp63.00 — trading 3.7% above its estimated fair value. The current 9-Day RSI is 59.23 and 16.7% above the Healthcare Providers & Services industry median of 50.77. PT Lippo Karawaci Tbk's overall GF Score™ is 69/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For PT Lippo Karawaci Tbk (ISX:LPKR), the current 9-Day RSI is 59.23 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Lippo Karawaci Tbk (ISX:LPKR) Overvalued in 2026?
Based on GuruFocus' analysis, PT Lippo Karawaci Tbk stock appears to be overvalued.
The current stock price of Rp63.00 is trading 3.7% above its estimated GF Value™ of Rp60.78.
GuruFocus considers PT Lippo Karawaci Tbk to be Fairly Valued.
Key valuation signals for ISX:LPKR:
9-Day RSI: 59.23
GF Value™: Rp60.78 vs. price of Rp63.00 (3.7% above fair value)
Industry Position: 16.7% above the Healthcare Providers & Services median (#491 of 698)
No single metric tells the full story. See the ISX:LPKR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Lippo Karawaci Tbk is engaged in property development activities including area development, residential property development and sales, commercial property, light industrial property, and integrated property projects. As part of its large scale integrated development portfolio, the Company develops projects within strategic locations comprising residential, office, mall, hotel, entertainment, education, and healthcare facilities. Its portfolio includes residential and urban development, hospitals, malls, and hotels and leisure assets. The Company has developed and manages urban property areas mainly in Java and Sulawesi, and operates across real estate, lifestyle, and healthcare segments, providing services across Indonesia.
69GF Score
Get the complete analysis for ISX:LPKR
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:LPKR has been successfully added to your 
